Atlas Trials

Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer

Clinical trial NCT04920656 · COMPLETED

Trial details

NCT number
NCT04920656
Sponsor
King Hussein Cancer Center
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2021-04-01
Primary completion
2025-02-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.